Kenneth Strauss

Kenneth I. Strauss, PhD, is an Associate Professor of Translational Science & Molecular Medicine, Michigan State University, Grand Rapids, Michigan who specializes in neurotrauma research.

Education

 * 1990, PhD, Molecular Biology & Biotechnology, Hahnemann University, Philadelphia, Pennsylvania
 * 1981, A.B., Biochemistry, Occidental College, Los Angeles, California

Notable studies

 * 1995, Long Term Improvements in Patients with Chronic Fatigue Syndrome Treated with Ampligen"'Abstract - Fifteen patients who fit the CDC definition of chronic fatigue syndrome (CFS) and had evidence of severe reduction in performance levels by low Kamofsky performance scores (KPS) of 20-60 were treated with Ampligen. At baseline most patients showed evidence of cerebral dysfunction by neuropsychological testing, were antigen positive by cell culture assay for human herpesvirus-6 (HHV-6), and displayed reduced performance during exercise tolerance testing, as measured by oxygen consumption. These patients represented a subset of CFS patients with especially severe and sustained symptomatology. Following 1248 weeks of Ampligen therapy, sustained improvements were noted in KPS (p < 0.01). Cognitive function improved including IQ and memory. Oxygen uptake and treadmill duration during exercise tolerance testing was also improved after 24 weeks of treatment (p < 0.01). Reduction in HHV-6 expression as measured by the giant cell assay was significant (p < 0.001). Patients continued to show significant improvement late in therapy, taking 8 to 12 weeks as baseline. It was concluded that while receiving Ampligen, the severely afflicted patients studied here derived long-lasting clinical benefit from the Ampligen therapy.'"

Learn more

 * Michigan State University faculty page
 * "UC Receives $1.7 Million to Study Molecular Treatment of Brain Injury"